Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M580Revenue $M13.5Net Margin (%)-690.0Altman Z-Score-2.7
Enterprise Value $M452EPS $-1.4Operating Margin %-566.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.4Pre-tax Margin (%)-690.0Higher ROA y-yY
Price/Book5.710-y EBITDA Growth Rate %-28.1Quick Ratio5.8Cash flow > EarningsY
Price/Sales34.25-y EBITDA Growth Rate %-16.1Current Ratio5.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-83.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-177.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M84.3ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with AGEN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGENGeorge Soros 2014-06-30 Sold Out $2.41 - $3.61
($2.94)
$ 6.88134%Sold Out0
AGENFirst Eagle Investment 2014-06-30 Sold Out $2.41 - $3.61
($2.94)
$ 6.88134%Sold Out0
AGENGeorge Soros 2014-03-31 Buy $2.64 - $5.1
($3.52)
$ 6.8895%New holding102,200
AGENFirst Eagle Investment 2014-03-31 Buy $2.64 - $5.1
($3.52)
$ 6.8895%New holding200,000
AGENRobert Bruce 2012-06-30 Buy 0.52%$4.84 - $6.9
($5.78)
$ 6.8819%New holding233,515
AGENRobert Bruce 2010-12-31 Buy $5.34 - $6.48
($5.71)
$ 6.8820%New holding233,517
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGEN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Malik ShahzadDirector 2015-04-29Sell1,107,377$7.11-3.23view
QVT Associates GP LLC10% Owner 2015-01-09Sell2,343,630$5.3129.57view
Wentworth KerryVP, Clinical, Reg & Qual 2014-02-26Sell5,000$537.6view
Malik ShahzadDirector 2014-02-12Sell0$037.6view
QVT Associates GP LLC10% Owner 2014-02-05Sell0$037.6view
Valentine KarenVP General Counsel 2014-01-23Sell2,850$3.596.57view
Baysal OzerChief Business Officer 2013-06-13Sell0$096.57view
Sharp ShaliniDirector 2013-01-30Sell288$4.3657.8view
Sharp ShaliniDirector 2012-10-31Sell288$4.456.36view
Sharp ShaliniDirector 2012-08-29Sell288$4.6448.28view

Quarterly/Annual Reports about AGEN:

News about AGEN:

Articles On GuruFocus.com
Paul Tudor Jones' Highest Performing Stocks Jul 13 2015 
rusty Jan 26 2015 
Agenus Inc.: Ingeniously Designed Vaccines To Galvanized Tomorrow's Medicine Jul 25 2014 
Agenus: Grossly Undervalued GlaxoSmithKline Acquisition Target Sep 10 2012 
5 Speculative Biotech Stocks to Consider Buying Now Jan 24 2012 
Weekly CEO Buys Highlight: CTAS, VRX, TAT, AGEN, MRK Aug 20 2011 
Chairman & CEO of Agenus Inc. (AGEN) Garo Armen Buys 2,150,976 Shares Aug 18 2011 
Antigenics Inc. Reports Operating Results (10-K) Mar 16 2011 
Antigenics Inc. Reports Operating Results (10-Q) Nov 09 2010 
Antigenics Inc. (AGEN) CFO Shalini Sharp sells 1,500 Shares Oct 28 2010 

More From Other Websites
Incyte & Hengrui to Develop Anti-PD-1 Monoclonal Antibody Sep 03 2015
Checkmate Pharma is latest cancer drug firm focused on immune system (BBJ photo gallery) Aug 12 2015
AGENUS INC Financials Aug 08 2015
10-Q for Agenus, Inc. Aug 05 2015
Edited Transcript of AGEN earnings conference call or presentation 23-Jul-15 3:00pm GMT Jul 24 2015
Malaria vaccine moves toward approval with Lexington biotech's help Jul 24 2015
AGENUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 24 2015
UPDATE 1-World's first malaria vaccine gets go-ahead from EU regulators Jul 24 2015
GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from... Jul 24 2015
Agenus (AGEN) Reports Wider-than-Expected Q2 Loss - Tale of the Tape Jul 23 2015
Agenus reports 2Q loss Jul 23 2015
Agenus reports 2Q loss Jul 23 2015
Q2 2015 Agenus Inc Earnings Release - Before Market Open Jul 23 2015
AGENUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jul 23 2015
Agenus Reports Second Quarter 2015 Financial Results Jul 23 2015
Will Agenus (AGEN) Disappoint Investors this Earnings? - Analyst Blog Jul 21 2015
AGENUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 20 2015
Agenus Acquires Novel Antibodies to Immuno-oncology Target CEACAM1 Jul 20 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK